The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Relaxin Modulates Cardiac Fibroblast Proliferation, Differentiation, and Collagen Production and Reverses Cardiac Fibrosis in Vivo
Abstract
Cardiac fibrosis is a key component of heart disease and involves the proliferation and differentiation of matrix-producing fibroblasts. The effects of an antifibrotic peptide hormone, relaxin, in inhibiting this process were investigated. We used rat atrial and ventricular fibroblasts, which respond to profibrotic stimuli and express the relaxin receptor (LGR7), in addition to two in vivo models of cardiac fibrosis. Cardiac fibroblasts, when plated at low density or stimulated with TGF-beta or angiotensin II (Ang II), accelerated fibroblast differentiation into myofibroblasts, as demonstrated by significantly increased alpha-smooth muscle actin expression, collagen synthesis, and collagen deposition (by up to 95% with TGF-beta and 40% with Ang II; all P < 0.05). Fibroblast proliferation was significantly increased by 10(-8) m and 10(-7) m Ang II (63-75%; P < 0.01) or 0.1-1 microg/ml IGF-I (27-40%; P < 0.05). Relaxin alone had no marked effect on these parameters, but it significantly inhibited Ang II- and IGF-I-mediated fibroblast proliferation (by 15-50%) and Ang II- and TGF-beta-mediated fibroblast differentiation, as detected by decreased expression of alpha-smooth muscle actin (by 65-88%) and collagen (by 60-80%). Relaxin also increased matrix metalloproteinase-2 expression in the presence of TGF-beta (P < 0.01) and Ang II (P < 0.05). Furthermore, relaxin decreased collagen overexpression when administered to two models of established fibrotic cardiomyopathy, one due to relaxin deficiency (by 40%; P < 0.05) and the other to cardiac-restricted overexpression of beta2-adrenergic receptors (by 58%; P < 0.01). These coherent findings indicate that relaxin regulates fibroblast proliferation, differentiation, and collagen deposition and may have therapeutic potential in diseased states characterized by cardiac fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cardiac interstitium in health and disease: The fibrillar collagen network
Weber, K. T. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90360-4 · Cited by 1,056
Matrix Metalloproteinase-2 Is an Interstitial Collagenase
Aimes, R. T., & Quigley, J. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.11.5872 · Cited by 944
Activation of Orphan Receptors by the Hormone Relaxin
Hsu, S. Y., Nakabayashi, K., Nishi, S., Kumagai, J., Kudo, M., Sherwood, O. D., & Hsueh, A. J. W. (2002) · Science · doi:10.1126/science.1065654 · Cited by 786
Molecular insights into renal interstitial fibrosis.
Eddy, A. A. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v7122495 · Cited by 637
Myofibroblasts differentiate from fibroblasts when plated at low density.
Masur, S. K., Dewal, H. S., Dinh, T. T., Erenburg, I., & Petridou, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4219 · Cited by 477
Induction of Cardiac Fibrosis by Transforming Growth Factor-β1
Lijnen, P. J., Petrov, V. V., & Fagard, R. H. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3032 · Cited by 464
Petrov, V. V., Fagard, R. H., & Lijnen, P. J. (2002) · Hypertension · doi:10.1161/hy0202.103268 · Cited by 419
Gray, M. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00121-7 · Cited by 417
Human Relaxin Gene 3 (H3) and the Equivalent Mouse Relaxin (M3) Gene
Bathgate, R. A. D., Samuel, C. S., Burazin, T. C. D., Layfield, S., Claasz, A. A., Reytomas, I. G. T., Dawson, N. F., Zhao, C., Bond, C., Summers, R. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107882200 · Cited by 378
Self-citationCampbell, S. E., & Katwa, L. C. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1997.0435 · Cited by 357
Unemori, E. N., Pickford, L. B., Salles, A. L., Piercy, C. E., Grove, B. H., Erikson, M. E., & Amento, E. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119099 · Cited by 340
Self-citationUnemori, E. N., & Amento, E. P. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)87000-4 · Cited by 321
Self-citationLee, A. A., Dillmann, W. H., McCulloch, A. D., & Villarreal, F. J. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(95)91983-x · Cited by 255
Posttranslational protein modifications, with special attention to collagen and elastin
Gallop, P. M., & Paz, M. A. (1975) · Physiological Reviews · doi:10.1152/physrev.1975.55.3.418 · Cited by 227
The pregnancy hormone relaxin is a player in human heart failure
Dschietzig, T., Richter, C., Bartsch, C., Laule, M., Armbruster, F. P., Baumann, G., & Stangl, K. (2001) · The FASEB Journal · doi:10.1096/fj.01-0070com · Cited by 211
Jugdutt, B. (2003) · Current Drug Target -Cardiovascular & Hematological Disorders · doi:10.2174/1568006033337276 · Cited by 199
Modulation of Smad2-mediated Signaling by Extracellular Signal-regulated Kinase
Funaba, M., Zimmerman, C. M., & Mathews, L. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204597200 · Cited by 196
Williams, E. J., Benyon, R. C., Trim, N., Hadwin, R., Grove, B. H., Arthur, M. J. P., Unemori, E. N., & Iredale, J. P. (2001) · Gut · doi:10.1136/gut.49.4.577 · Cited by 186
Self-citationRadioimitnunoassay of Relaxin throughout Pregnancy and during Parturition in the Rat*
SHERWOOD, O. D., CRNEKOVIC, V. E., GORDON, W. L., & RUTHERFORD, J. E. (1980) · Endocrinology · doi:10.1210/endo-107-3-691 · Cited by 179
Regulation of cardiovascular collagen synthesis by mechanical load
Bishop, J. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00021-8 · Cited by 177
Talhouk, R. S., Chin, J. R., Unemori, E. N., Werb, Z., & Bissell, M. J. (1991) · Development · doi:10.1242/dev.112.2.439 · Cited by 176
Self-citationAngiotensin II Activates Collagen I Gene Through a Mechanism Involving the MAP/ER Kinase Pathway
Tharaux, P.-L., Chatziantoniou, C., Fakhouri, F., & Dussaule, J.-C. (2000) · Hypertension · doi:10.1161/01.hyp.36.3.330 · Cited by 173
McEwan, P. E., Gray, G. A., Sherry, L., Webb, D. J., & Kenyon, C. J. (1998) · Circulation · doi:10.1161/01.cir.98.24.2765 · Cited by 172
Dschietzig, T., Bartsch, C., Richter, C., Laule, M., Baumann, G., & Stangl, K. (2003) · Circulation Research · doi:10.1161/01.res.0000051884.27117.7e · Cited by 169
Relaxin deficiency in mice is associated with an age‐related progression of pulmonary fibrosis
Samuel, C. S., Zhao, C., Bathgate, R. A. D., Bond, C. P., Burton, M. D., Parry, L. J., Summers, R. J., Tang, M. L. K., Amento, E. P., & Tregear, G. W. (2003) · The FASEB Journal · doi:10.1096/fj.02-0449fje · Cited by 168
Self-citationDu, X. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00663-6 · Cited by 156
Self-citationRelaxin decreases renal interstitial fibrosis and slows progression of renal disease
Garber, S. L., Mirochnik, Y., Brecklin, C. S., et al. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059003876.x · Cited by 152
Samuel, C. S., Butkus, A., Coghlan, J. P., & Bateman, J. F. (1996) · Endocrinology · doi:10.1210/endo.137.9.8756561 · Cited by 141
Self-citationCardiac fibroblasts: function, regulation of gene expression, and phenotypic modulation
Eghbali, M. (1992) · Steinkopff eBooks · doi:10.1007/978-3-642-72477-0_16 · Cited by 136
Is angiotensin II a proliferative factor of cardiac fibroblasts?
Bouzegrhane, F., & Thibault, G. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00448-5 · Cited by 109
Relaxin signalling links tyrosine phosphorylation to phosphodiesterase and adenylyl cyclase activity
Bartsch, O. (2001) · Molecular Human Reproduction · doi:10.1093/molehr/7.9.799 · Cited by 106
Angiotensin II induces TIMP-1 production in rat heart endothelial cells
Chua, C. C., Hamdy, R. C., & Chua, B. H. L. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(95)00205-7 · Cited by 100
Relaxin activates the MAP kinase pathway in human endometrial stromal cells
Zhang, Q., Liu, S., Erikson, M. E., Lewis, M., & Unemori, E. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10150 · Cited by 85
Self-citationSex Hormones and Cardiomyopathic Phenotype Induced by Cardiac β2-Adrenergic Receptor Overexpression
Gao, X., Agrotis, A., Autelitano, D. J., Percy, E., Woodcock, E. A., Jennings, G., Dart, A. M., & Du, X. (2003) · Endocrinology · doi:10.1210/en.2002-0214 · Cited by 81
Self-citationPalejwala, S., Stein, D. E., Wojtczuk, A. S., et al. (1998) · Endocrinology · doi:10.1210/endo.139.3.5772 · Cited by 80
Kompa, A. R., Samuel, C. S., & Summers, R. J. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704922 · Cited by 67
Self-citationRelaxin clinical trials in systemic sclerosis
Erikson, M. S., & Unemori, E. (2001) · Springer eBooks · doi:10.1007/978-94-017-2877-5_62 · Cited by 67
Self-citationAngiotensin II induces TGF-β1 production in rat heart endothelial cells
Chua, C. C., Diglio, C. A., Siu, B. B., & Chua, B. H. L. (1994) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(94)90083-3 · Cited by 40
van Eickels, M., Vetter, H., & Grohé, C. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703740 · Cited by 30
Cited by
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Cardiac fibroblasts: At the heart of myocardial remodeling
Porter, K. E., & Turner, N. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.05.002 · Cited by 1,010
Tan, Y., Zhang, Z., Zheng, C., Wintergerst, K. A., Keller, B. B., & Cai, L. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0339-2 · Cited by 835
Relaxin family peptides and their receptors
Bathgate, R. A. D., Halls, M. L., van der Westhuizen, E. T., Callander, G. E., Kocan, M., & Summers, R. J. (2013) · Physiological Reviews · doi:10.1152/physrev.00001.2012 · Cited by 534
Self-citationKhan, R., & Sheppard, R. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02336.x · Cited by 501
Metadata
- Authors
- Samuel, C. S., Unemori, E. N., Mookerjee, I., Bathgate, R. A. D., Layfield, S. L., Mak, J., Tregear, G. W., & Du, X.-J.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2004-09-01
- Volume
- 145
- Issue
- 9
- Pages
- 4125-4133
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2018492901
- Cited by
- 288
- References
- 39
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.